Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, March 2008, p. 1140-1143, Vol. 52, No. 3
0066-4804/08/$08.00+0 doi:10.1128/AAC.01352-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Division of Bacterial Diseases, Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia 30333,1 Minnesota Department of Health, St. Paul, Minnesota 551642
Received 19 October 2007/ Returned for modification 15 November 2007/ Accepted 14 December 2007
|
|
|---|
|
|
|---|
In GAS, macrolide resistance is conferred by the 23S rRNA methylase genes erm(B) and erm(TR), as well as by the efflux determinant mef(A) (12, 15). The erm(B) and erm(TR) genes often confer inducible resistance to macrolides, lincosamides, and streptogramin B, but also may encode constitutive resistance to macrolides, lincosamides, and streptogramin B due to upstream attenuator sequence alterations. mef(A) encodes efflux pump-mediated resistance to erythromycin (and other 14- or 15-member ring macrolides), while the organism remains susceptible to clindamycin (and other lincosamides) and streptogramin B. Aquisition of macrolide resistance primarily occurs by horizontal gene transfer of erm or mef genes (4, 13), while more rarely resistance results from mutations within genes encoding ribosomal components (12). The erm(B) and erm(TR) genes often confer cross-resistance to both lincosamides and streptogramins and therefore limit the therapeutic possibilities available to clinicians for the treatment of GAS disease (12).
In this study, we identified the genetic basis of macrolide and inducible clindamycin resistance in 23 invasive GAS isolates that were negative for macrolide resistance determinants known to be disseminated among resistant GAS (5, 16, 18). These 23 isolates were collected among all invasive GAS infections reported during 1999, 2001, and 2003 (3,189 reported cases) from CDC's population-based Active Bacterial Core surveillance conducted in 10 sites throughout the United States (http://www.cdc.gov/ncidod/dbmd/abcs/).
Susceptibility to erythromycin was determined by the broth dilution technique with a standard panel of antibiotics, including erythromycin and clindamycin. The double-disk diffusion (D) test (4, 16) confirmed erythromycin resistance and detected inducible clindamycin resistance. Mueller-Hinton agar plates supplemented with 5% sheep blood were inoculated with a suspension of GAS that met a McFarland 0.5 turbidity standard. An erythromycin disk containing 15 µg and a clindamycin disk containing 2 µg were placed 12 mm apart (edge to edge). Resistance to erythromycin with blunting of the zone of inhibition around the clindamycin disk facing the side of the erythromycin disk indicated inducible clindamycin resistance.
PCR was performed for detection of erm(A), erm(B), and erm(C) (18). Detection of erm(TR) and mef determinants employed primers designed at the Minnesota Department of Health (Table 1). PCRs for erm(TR) and mef contained 10 mM Tris HCl, 50 mM KCl, 1.5 mM MgCl2, 1 µM each forward and reverse primers, and 2 µl of template DNA in a total volume of 50 µl. Annealing temperatures were 55°C for erm(TR) and 56°C for mef. When PCR assays were negative for the erm and mef determinants described above, erm(T)-specific primers (Table 1) were subsequently used to detect a PCR product of 478 bp from all 23 isolates after electrophoresis on 2% agarose gels.
|
View this table: [in a new window] |
TABLE 1. PCR primers used in this study for detection of macrolide resistance genes
|
![]() View larger version (34K): [in a new window] |
FIG. 1. (A) Diagram of pRW35. Three ORFs are indicated. (B) Nearly identical attenuator and translational start regions of erm(T) from S. pyogenes and Streptococcus pasteurianus. The sequences encompassing the leader peptide-encoding sequence and erm(T) translational start are shown. Perfect and imperfect inverted repeats are indicated with arrows. Pairing of inverted repeats 5 and 6 represents the putative active conformation according to the erm(C) model (10). Pairing of inverted repeats 1 and 2 and 3 and 4 represents the putative inactive conformation in which the erm(T) ribosome binding site (RBS) and translation initiation codon are sequestered by pairing of inverted repeats 3 and 4. The RBS, translational start codons, and leader peptide translational stop codons are in bold.
|
98%) to the erythromycin resistance methylase gene erm(T) found on a transposon in Streptococcus gallolyticus subsp. pasteurianus (20) as well as plasmid-borne erm(T) determinants from Lactobacillus reuteri (19), Lactobacillus sp. (23), and Streptococcus bovis (NCBI accession no. BAA75016). In addition to erm(T), pRW35 contains two ORFs highly similar to plasmid replication and transfer genes found in broad-host-range plasmids. ORF2 predicts a protein highly similar (>60%) to mobilization proteins from Streptococcus agalactiae, Lactococcus lactis, and Streptococcus bovis (14, 21). An attenuator region upstream of erm(T) in pRW35 nearly identical to its counterpart in S. gallolyticus subsp. pasteurianus was identified (Fig. 1B). This region shares features with the corresponding region upstream of the S. aureus plasmid-borne erm(C) (7) and is predicted to share the same mechanism of regulating translation of the erm(T) message (3, 7). During induction by erythromycin, sensitive ribosomes are stalled upon the upstream leader peptide favoring formation of hairpin structure 5-6 (active conformation). As the proportion of resistant ribosomes increases (originally present in relatively small numbers) to a critical level, translation of the erm(T) message greatly decreases due to a shift of the message to the inactive conformation (1-2 and 3-4 hairpins) that results in sequestration of the erm(T) translational start and ribosome binding site.
emm typing (2; www.cdc.gov/ncidod/biotech/strep/protocol_emm-type.htm) identified four unique types among the 23 erm(T)-positive isolates, including emm92 (19 isolates), emm3 (2 isolates), emm9, and emm28 (Table 2). The 19 emm92 isolates formed a distinct cluster of highly related pulsed-field gel electrophoresis (PFGE) patterns, and the two emm3 isolates displayed an additional distinct PFGE profile (data not shown). The emm9 and emm28 isolates represented two additional distinct patterns. The T types from all of the isolates and PFGE profiles from types emm92, emm3, and emm28 conformed to patterns typically associated with erythromycin-sensitive strains of the same emm types (9; unpublished data), indicating that the emergence of erm(T)-positive GAS is not associated with newly emerging clonal types.
|
View this table: [in a new window] |
TABLE 2. Features of invasive GAS isolates containing erm(T)
|
32 µg/ml) and inducibly clindamycin resistant (12 µg/ml). All transformants were positive for erm(T) and the entire circular plasmid pRW35 by PCR analysis. These results indicated that pRW35 conferred erythromycin and inducible clindamycin resistance as a replicative plasmid in the distantly related group B species and in a heterologous S. pyogenes strain. In summary, our data indicate that plasmid pRW25 is disseminated among multiple unrelated GAS strains, including classical opacity factor-positive (types emm28, emm9, and emm92) and -negative (emm3) strains. Transformation of pRW25 into S. agalactiae and an additional GAS strain as a replicative plasmid is consistent with the hypothesis that pRW35 is capable of dissemination to a broad range of hosts. erm(T)-specific primers may be useful in subsequent PCR screens for macrolide resistance determinants among GAS.
We thank members of the CDC/RDB Streptococcus Laboratory for serotyping, antibiotic susceptibility testing, and sequencing. Robyn Woodbury was supported by the FIRST Institutional Research and Academic Career Development Award (K12) through the Division of Minority Opportunities in Research at the National Institute of General Medical Sciences, National Institutes of Health.
Published ahead of print on 7 January 2008. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»